Clinical Trials Directory

Trials / Conditions / Refractory Pancreatic Carcinoma

Refractory Pancreatic Carcinoma

6 registered clinical trials studyying Refractory Pancreatic Carcinoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingCPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Pati
NCT05733000
Northwestern UniversityPhase 2
RecruitingTesting A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
NCT05053971
National Cancer Institute (NCI)Phase 1 / Phase 2
WithdrawnTesting a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumor
NCT03925428
National Cancer Institute (NCI)Phase 1
CompletedA Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors
NCT03784677
M.D. Anderson Cancer CenterPhase 1
Active Not RecruitingDanvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung C
NCT02983578
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingM6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Rem
NCT02595931
National Cancer Institute (NCI)Phase 1